UNVR · Univar Solutions Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.57B | $2.68B | - | $2.98B | $3.02B | $2.88B | - | $2.49B | $2.39B | $2.16B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $289.50M | $306.50M | - | $324.80M | $318.70M | $294.30M | - | $299.70M | $307.20M | $268.80M |
| Total Operating Expenses | $461.90M | $493.10M | - | $497.30M | $493.90M | $470.60M | - | $473.20M | $487.50M | $461.30M |
| D&A | $33.90M | $43.60M | - | $32.80M | $32.20M | $44.70M | - | $36.70M | $37.30M | $56.90M |
| Operating Income | $162.90M | $146.20M | - | $208.80M | $242.10M | $258.90M | - | $143.20M | $115.00M | $81.10M |
| Interest Expense | $33.80M | $33.20M | - | $27.60M | $24.30M | $22.20M | - | $23.70M | $26.40M | $27.00M |
| Income Tax | $34.20M | $25.30M | - | $52.60M | $58.60M | $64.70M | - | $37.70M | $27.00M | $17.60M |
| Net Income | $87.80M | $83.10M | - | $130.00M | $162.90M | $180.80M | - | $84.40M | $153.20M | $66.20M |
| EPS - Basic | $0.56 | $0.53 | - | $0.78 | $0.97 | $1.07 | - | $0.49 | $0.90 | $0.39 |
| EPS - Diluted | $0.55 | $0.52 | - | $0.78 | $0.96 | $1.06 | - | $0.49 | $0.90 | $0.39 |
Balance Sheet
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $429.50M | $377.70M | $385.30M | $276.30M | $234.80M | $251.50M | $251.50M | $220.80M | $207.00M | $141.40M |
| Accounts Receivable | $1.50B | $1.58B | $1.49B | $1.73B | $1.82B | $1.81B | $1.54B | $1.56B | $1.53B | $1.42B |
| Inventory | $994.80M | $1.09B | $1.14B | $1.17B | $1.21B | $1.11B | $932.20M | $840.60M | $786.10M | $728.40M |
| Accounts Payable | $914.40M | $968.00M | $982.50M | $1.04B | $1.15B | $1.15B | $1.01B | $944.90M | $953.10M | $878.40M |
| Current Assets | $3.16B | $3.25B | $3.23B | $3.39B | $3.49B | $3.36B | $2.89B | $2.79B | $2.70B | $2.51B |
| Total Assets | $7.25B | $7.19B | $7.15B | $7.27B | $7.38B | $7.27B | $6.78B | $6.59B | $6.55B | $6.37B |
| Current Liabilities | $1.45B | $1.49B | $1.63B | $1.64B | $1.71B | $1.72B | $1.67B | $1.56B | $1.57B | $1.45B |
| Long-term Debt | - | - | $2.38B | - | - | - | $2.18B | - | - | - |
| Total Liabilities | $4.52B | $4.60B | $4.65B | $4.70B | $4.80B | $4.76B | $4.49B | $4.42B | $4.45B | $4.50B |
| Stockholders' Equity | $2.74B | $2.59B | $2.49B | $2.56B | $2.58B | $2.52B | $2.29B | $2.16B | $2.10B | $1.87B |
| Retained Earnings | $371.20M | $283.40M | $200.30M | $128.70M | ($1.30M) | ($164.20M) | ($345.00M) | ($501.80M) | ($586.20M) | ($739.40M) |
Cash Flow
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($2.90M) | - | - | - | ($134.40M) | - | - | - | ($92.30M) |
| Investing Cash Flow | - | ($51.40M) | - | - | - | ($34.50M) | - | - | - | ($12.20M) |
| Financing Cash Flow | - | $38.90M | - | - | - | $170.80M | - | - | - | ($133.70M) |
| CapEx | - | $39.10M | - | - | - | $32.50M | - | - | - | $16.30M |
| Free Cash Flow | - | ($42.00M) | - | - | - | ($166.90M) | - | - | - | ($108.60M) |
Ratios
| Metric | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 6.3% | 5.4% | - | 7.0% | 8.0% | 9.0% | - | 5.8% | 4.8% | 3.8% |
| EBITDA margin | 7.6% | 7.1% | - | 8.1% | 9.1% | 10.5% | - | 7.2% | 6.4% | 6.4% |
| Net margin | 3.4% | 3.1% | - | 4.4% | 5.4% | 6.3% | - | 3.4% | 6.4% | 3.1% |
| Free cash flow margin | - | -1.6% | - | - | - | -5.8% | - | - | - | -5.0% |
| FCF / Net income | - | -0.51 | - | - | - | -0.92 | - | - | - | -1.64 |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 11.2% | 11.4% | - | 10.9% | 10.6% | 10.2% | - | 12.0% | 12.8% | 12.5% |
| Effective tax rate | 28.0% | 23.3% | - | 28.8% | 26.5% | 26.4% | - | 30.9% | 15.0% | 21.0% |
| Return on assets | 1.2% | 1.2% | - | 1.8% | 2.2% | 2.5% | - | 1.3% | 2.3% | 1.0% |
| Return on equity | 3.2% | 3.2% | - | 5.1% | 6.3% | 7.2% | - | 3.9% | 7.3% | 3.5% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.18 | 2.18 | 1.99 | 2.07 | 2.04 | 1.95 | 1.73 | 1.79 | 1.72 | 1.73 |
| Quick ratio | 1.49 | 1.45 | 1.29 | 1.36 | 1.33 | 1.31 | 1.18 | 1.25 | 1.22 | 1.23 |
| Cash ratio | 0.30 | 0.25 | 0.24 | 0.17 | 0.14 | 0.15 | 0.15 | 0.14 | 0.13 | 0.10 |
| Leverage | ||||||||||
| Debt / Equity | - | - | 0.95 | - | - | - | 0.95 | - | - | - |
| Debt / Assets | - | - | 0.33 | - | - | - | 0.32 | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 4.8x | 4.4x | - | 7.6x | 10.0x | 11.7x | - | 6.0x | 4.4x | 3.0x |
| Equity multiplier | 2.65 | 2.78 | 2.86 | 2.83 | 2.86 | 2.89 | 2.96 | 3.04 | 3.12 | 3.41 |
| Liabilities / Assets | 0.62 | 0.64 | 0.65 | 0.65 | 0.65 | 0.65 | 0.66 | 0.67 | 0.68 | 0.71 |
| Efficiency | ||||||||||
| Asset turnover | 0.35 | 0.37 | - | 0.41 | 0.41 | 0.40 | - | 0.38 | 0.37 | 0.34 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 213d | 214d | - | 212d | 221d | 229d | - | 229d | 234d | 241d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -14.7% | -6.9% | - | 19.9% | 26.0% | 33.7% | - | 23.8% | 19.2% | -2.5% |
| Revenue CAGR (3y) | 8.6% | 6.7% | - | 7.7% | 5.3% | 10.1% | - | 6.7% | 0.3% | 2.5% |
| Revenue CAGR (5y) | 1.6% | 6.1% | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | -32.7% | -43.5% | - | 45.8% | 110.5% | 219.2% | - | 116.3% | 143.6% | -18.9% |
| Net income growth (YoY) | -46.1% | -54.0% | - | 54.0% | 6.3% | 173.1% | - | 192.0% | 8411.1% | 18.4% |
| EPS growth (YoY) | -42.7% | -50.9% | - | 59.2% | 6.7% | 171.8% | - | 188.2% | 8900.0% | 18.2% |
| EPS CAGR (3y) | 280.3% | 16.4% | - | 327.3% | 112.5% | - | - | 11.9% | 31.0% | -5.4% |
| EPS CAGR (5y) | 6.6% | 2.5% | - | 22.7% | 34.3% | 46.0% | - | 40.3% | 25.4% | 31.3% |
| FCF growth (YoY) | - | 74.8% | - | - | - | -53.7% | - | - | - | -6.2% |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 6.1% | 3.0% | 8.8% | 18.5% | 22.9% | 34.7% | 27.9% | 23.6% | 23.2% | 11.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2022-12-31.
Product / service
$7.53B totalChemical Distribution$7.25B · 96.2%
Services$286.20M · 3.8%
Geographic
$11.48B totalUS$7.53B · 65.6%
EMEA$2.06B · 18.0%
CA$1.12B · 9.8%
Latin America$756.60M · 6.6%
Peer comparison
Same SIC group: Wholesale-Chemicals & Allied Products
Comparing Univar Solutions Inc. against the 2 most active filers in the same SIC group.